spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stefansson, S.
Right arrow Articles by Argraves, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stefansson, S.
Right arrow Articles by Argraves, W. S.

Journal of Cell Science, Vol 108, Issue 6 2361-2368, Copyright © 1995 by Company of Biologists


JOURNAL ARTICLES

gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex

S Stefansson, MZ Kounnas, J Henkin, RK Mallampalli, DA Chappell, DK Strickland and WS Argraves
Biochemistry Department, J. H. Holland Laboratory, American Red Cross, Rockville, MD 20855, USA.

Glycoprotein 330 (gp330) is a member of a family of receptors related to the low density lipoprotein receptor (LDLR). Although several ligands have been shown to bind gp330 in solid-phase assays, the ability of gp330 to mediate ligand endocytosis has not been demonstrated. To develop a cellular model for gp330 function we screened a variety of cultured cell lines and identified several that expressed this protein, including immortalized rat type II pneumocytes and a human and two rodent tumor cell lines. Using type II pneumocytes, endocytosis of a previously described gp330 ligand, urokinase (uPA) complexed with plasminogen activator inhibitor-1 (uPA:PAI-1) and two new ligands, PAI-1 and pro-uPA, was demonstrated. RAP, the 39 kDa receptor-associated protein known to antagonize ligand binding to gp330 in solid-phase binding assays, completely inhibited both internalization and degradation of the radiolabeled ligands by type II pneumocytes. This suggested that the clearance of these ligands was dependent on either gp330 or the LDLR-related protein (LRP), which shares several ligand-binding characteristics with gp330. By using polyclonal antibodies to gp330, the cellular internalization and degradation of the ligands were inhibited by 30-50%; remaining ligand internalization and degradation activity could be partially inhibited by polyclonal antibodies against LRP. These findings indicate that gp330, like other LDLR family members, mediates endocytosis of its ligands. In addition, gp330 acts in concert with LRP in type II pneumocytes to mediate clearance of a variety of proteins involved in plasminogen activation, including uPA:PAI-1 complexes PAI-1 and pro-uPA.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
A. P. Lillis, L. B. Van Duyn, J. E. Murphy-Ullrich, and D. K. Strickland
LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies
Physiol Rev, July 1, 2008; 88(3): 887 - 918.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Croucher, D. N. Saunders, and M. Ranson
The Urokinase/PAI-2 Complex: A NEW HIGH AFFINITY LIGAND FOR THE ENDOCYTOSIS RECEPTOR LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN
J. Biol. Chem., April 14, 2006; 281(15): 10206 - 10213.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. Zhang, X. Cai, J. M. Lopez-Guisa, S. J. Collins, and A. A. Eddy
Mitogenic Signaling of Urokinase Receptor-Deficient Kidney Fibroblasts: Actions of an Alternative Urokinase Receptor and LDL Receptor-Related Protein
J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2090 - 2102.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Stefansson, M. Yepes, N. Gorlatova, D. E. Day, E. G. Moore, A. Zabaleta, G. A. McMahon, and D. A. Lawrence
Mutants of Plasminogen Activator Inhibitor-1 Designed to Inhibit Neutrophil Elastase and Cathepsin G Are More Effective in Vivo than Their Endogenous Inhibitors
J. Biol. Chem., July 16, 2004; 279(29): 29981 - 29987.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. J. Ryan, J. D. Medh, D. M. McCoy, R. G. Salome, and R. K. Mallampalli
Maternal loading with very low-density lipoproteins stimulates fetal surfactant synthesis
Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L310 - L318.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. McCarthy, J. L. Barth, M. R. Chintalapudi, C. Knaak, and W. S. Argraves
Megalin Functions as an Endocytic Sonic Hedgehog Receptor
J. Biol. Chem., July 5, 2002; 277(28): 25660 - 25667.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. I. Christensen and H. Birn
Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule
Am J Physiol Renal Physiol, April 1, 2001; 280(4): F562 - F573.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
C. Foca, E.K. Moses, M.A. Quinn, and G.E. Rice
Differential expression of the {alpha}2-macroglobulin receptor and the receptor associated protein in normal human endometrium and endometrial carcinoma
Mol. Hum. Reprod., October 1, 2000; 6(10): 921 - 927.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Hammad, J. L. Barth, C. Knaak, and W. S. Argraves
Megalin Acts in Concert with Cubilin to Mediate Endocytosis of High Density Lipoproteins
J. Biol. Chem., April 14, 2000; 275(16): 12003 - 12008.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Marino, G. Zheng, L. Chiovato, A. Pinchera, D. Brown, D. Andrews, and R. T. McCluskey
Role of Megalin (gp330) in Transcytosis of Thyroglobulin by Thyroid Cells. A NOVEL FUNCTION IN THE CONTROL OF THYROID HORMONE RELEASE
J. Biol. Chem., March 15, 2000; 275(10): 7125 - 7137.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. BIRN, H. VORUM, P. J. VERROUST, S. K. MOESTRUP, and E. I. CHRISTENSEN
Receptor-Associated Protein Is Important for Normal Processing of Megalin in Kidney Proximal Tubules
J. Am. Soc. Nephrol., February 1, 2000; 11(2): 191 - 202.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. I. CHRISTENSEN and T. E. WILLNOW
Essential Role of Megalin in Renal Proximal Tubule for Vitamin Homeostasis
J. Am. Soc. Nephrol., October 1, 1999; 10(10): 2224 - 2236.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Marinò, L. Chiovato, J. A. Friedlander, F. Latrofa, A. Pinchera, and R. T. McCluskey
Serum Antibodies against Megalin (GP330) in Patients with Autoimmune Thyroiditis
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2468 - 2474.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Marino, G. Zheng, and R. T. McCluskey
Megalin (gp330) Is an Endocytic Receptor for Thyroglobulin on Cultured Fisher Rat Thyroid Cells
J. Biol. Chem., April 30, 1999; 274(18): 12898 - 12904.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Webb, D. H. D. Nguyen, M. Sankovic, and S. L. Gonias
The Very Low Density Lipoprotein Receptor Regulates Urokinase Receptor Catabolism and Breast Cancer Cell Motility in Vitro
J. Biol. Chem., March 12, 1999; 274(11): 7412 - 7420.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ranganathan, C. Knaak, C. R. Morales, and W. S. Argraves
Identification of Low Density Lipoprotein Receptor-related Protein-2/megalin as an Endocytic Receptor for Seminal Vesicle Secretory Protein II
J. Biol. Chem., February 26, 1999; 274(9): 5557 - 5563.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. ZIAK, D. KERJASCHKI, M. G. FARQUHAR, and J. ROTH
Identification of Megalin as the Sole Rat Kidney Sialoglycoprotein Containing Poly {alpha}2,8 Deaminoneuraminic Acid
J. Am. Soc. Nephrol., February 1, 1999; 10(2): 203 - 209.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Stefansson, S. Muhammad, X.-F. Cheng, F. D. Battey, D. K. Strickland, and D. A. Lawrence
Plasminogen Activator Inhibitor-1 Contains a Cryptic High Affinity Binding Site for the Low Density Lipoprotein Receptor-related Protein
J. Biol. Chem., March 13, 1998; 273(11): 6358 - 6366.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. M. Hammad, S. Ranganathan, E. Loukinova, W. O. Twal, and W. S. Argraves
Interaction of Apolipoprotein J-Amyloid beta -Peptide Complex with Low Density Lipoprotein Receptor-related Protein-2/Megalin. A MECHANISM TO PREVENT PATHOLOGICAL ACCUMULATION OF AMYLOID beta -PEPTIDE
J. Biol. Chem., July 25, 1997; 272(30): 18644 - 18649.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. A. Orlando, M. Exner, R.-P. Czekay, H. Yamazaki, A. Saito, R. Ullrich, D. Kerjaschki, and M. G. Farquhar
Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions
PNAS, March 18, 1997; 94(6): 2368 - 2373.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Stefansson, D. A. Lawrence, and W. S. Argraves
Plasminogen Activator Inhibitor-1 and Vitronectin Promote the Cellular Clearance of Thrombin by Low Density Lipoprotein Receptor-related Proteins 1 and 2
J. Biol. Chem., April 5, 1996; 271(14): 8215 - 8220.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Stefansson, D. A. Chappell, K. M. Argraves, D. K. Strickland, and W. S. Argraves
Glycoprotein 330/Low Density Lipoprotein Receptor-related Protein-2 Mediates Endocytosis of Low Density Lipoproteins via Interaction with Apolipoprotein B100
J. Biol. Chem., August 18, 1995; 270(33): 19417 - 19421.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 1995